EMERSON PERIN to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications EMERSON PERIN has written about Randomized Controlled Trials as Topic.
Connection Strength
0.880
-
Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure. Circ Res. 2019 07 19; 125(3):265-281.
Score: 0.454
-
Radiation exposure during distal and traditional radial coronary angiography and percutaneous coronary intervention: a meta-analysis of randomized controlled trials. J Invasive Cardiol. 2023 Nov; 35(11).
Score: 0.153
-
Gene therapy for diabetic foot ulcers: Interim analysis of a randomised, placebo-controlled phase 3 study of VM202 (ENGENSIS), a plasmid DNA expressing two isoforms of human hepatocyte growth factor. Int Wound J. 2023 Nov; 20(9):3531-3539.
Score: 0.148
-
A critical analysis of clinical outcomes reported in stem cell trials for acute myocardial infarction: some thoughts for design of future trials. Curr Atheroscler Rep. 2013 Aug; 15(8):341.
Score: 0.075
-
Association between High Endocardial Unipolar Voltage and Improved Left Ventricular Function in Patients with Ischemic Cardiomyopathy. Tex Heart Inst J. 2016 Aug; 43(4):291-6.
Score: 0.023
-
Outcomes of unselected recipients of sirolimus-eluting stents: the Cypher stent U.S. post-marketing surveillance registry. J Invasive Cardiol. 2010 Feb; 22(2):48-55.
Score: 0.015
-
Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med. 2007 May 28; 167(10):989-97.
Score: 0.012